Tech Center 1600 • Art Units: 1634 1641 1674 1677
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18340917 | NON-HUMAN ANIMALS HAVING A HUMANIZED CLEC9A GENE | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18115285 | BIOREACTOR FOR ANTIBODY PRODUCTION | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17918830 | MODIFIED CCR POLYPEPTIDES AND USES THEREOF | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18342930 | LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS | Non-Final OA | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18344973 | MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS | Non-Final OA | JANSSEN BIOTECH, INC. |
| 18345951 | TMPRSS KNOCKOUT SWINE HAVING A REDUCED SUSCEPTIBILITY TO INFLUENZA | Non-Final OA | Kansas State University Research Foundation |
| 17996573 | SIRPa Deficient Macrophages for Treating Cancer | Non-Final OA | Georgia State University Research Foundation, Inc. |
| 18348292 | TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT | Non-Final OA | CREATIVE MEDICAL TECHNOLOGIES, INC. |
| 18350892 | Method for Obtaining Cultures of Mesenchymal Stem Cells (MSCs) from the Perivascular Space of the Umbilical Cord Vessel | Non-Final OA | BAOSHENGTANG BIOTECH CO., LTD. |
| 17999987 | COMPOSITIONS AND METHODS FOR NEGATIVE SELECTION OF NAIVE T AND B CELLS WITH A SINGLE ANTIBODY | Non-Final OA | BioMagnetic Solutions LLC |
| 18135945 | CHIMERIC ADAPTOR PROTEINS AND METHODS OF REGULATING GENE EXPRESSION | Non-Final OA | FUNDAÇÃO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy